Rakovina Therapeutics Announces Appointment of New Scientific Advisory Board Member
Yale physician-scientist and biotech entrepreneur Dr. Ranjit Bindra brings deep expertise in DNA repair, synthetic lethality and brain tumor therapeutics VANCOUVER, British Columbia, Sept. 17, 2026 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0) a biopharmaceutical company advancing innovative cancer therapies through AI-powered drug discovery, today announced the…
We haven't written up this one. Financial Post has the full story — the link below goes straight to it.
